Vimarsana
Biggest News Aggregation in the World

Page 8 - Randomized Controlled Trials News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Randomized Controlled Trials. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Randomized Controlled Trials Today - Breaking & Trending Today

The Final Brick in the Vaccine Efficacy Narrative - Vimarsana News

The Final Brick in the Vaccine Efficacy Narrative

Commentary Two key bricks seem to have already fallen from the COVID vaccines’ narrative—the one about their fantastic ...

Ironwood to Present New Data at Digestive Disease Week® 2023 Demonstrating Potential of Linaclotide for Functional Constipation in Children and Adolescents Ages 6-17 Years-Old - Vimarsana News

Ironwood to Present New Data at Digestive Disease Week® 2023 Demonstrating Potential of Linaclotide for Functional Constipation in Children and Adolescents Ages 6-17 Years-Old

– Pivotal Phase III data will be spotlighted via an oral presentation – – Additional efficacy and safety data will be featured across four posters – ... | June 18, 2023

Food we consume is becoming less nutritious: and it's s... - Vimarsana News

Food we consume is becoming less nutritious: and it's s...

Food nutrition: Solutions are not at all simple particularly in terms of from agricultural and consumer practices.

Considering Cannabinoid Topical Agents for Pain Management - Vimarsana News

Considering Cannabinoid Topical Agents for Pain Management

Topical analgesics, including those with CBD, are effective as a complement to other pain management strategies. 

Changing mindsets, changing lives: The power of social norms programming in ending child marriage - Vimarsana News

Changing mindsets, changing lives: The power of social norms programming in ending child marriage

Care Bangladesh in association with The Daily Star organized a roundtable titled “Impact of Social Norms Programming” on February 28, 2023. Here we publish a summary of the discussion.